網路藥局 (線上藥局) 市場 - 目前分析與預測:2021年∼2027年
e-Pharmacy Market: Current Analysis and Forecast (2021-2027)
本報告提供全球網路藥局 (線上藥局) 市場相關調查分析，市場考察，市場動態，主要企業等相關的系統性資訊。
The e-pharmacy is an online pharmacy, which runs across the internet and delivers medicine to consumers through mail or shipping companies. The e-pharmacy cut off the long chain of suppliers and directly delivers medicine to the end-users at a reduced price. For instance, according to The Hindu in August 2019, the pharmacy chains such as MedPlus encourage online booking by offering discounts. The average discount on prescription drugs when a visit to a physical store is 10% (for purchases of up to USD 13.43). However, if the order is online, the discount consumers get is up to 20% on the maximum price. Further, the growing geriatric population is increasing the chances of chronic diseases and boosting the need for online Pharmacy for the easy delivery of medicines and healthcare devices. According to the United States Department of Economic and Social Affairs, globally there were around 727 million people aged 65 years or more in the world in 2020. And this share of the global population aged 65 years or above is expected to increase from 9.3% in 2020 to 16% by 2050.
Moreover, some factors that will hinder the growth of this market include the increasing fraud activities and strict adherence to regulatory guidelines. Also, the rising security and privacy concern among consumers is estimated to limit the growth of this market during the forecast period.
During the COVID-19 pandemic, the e-Pharmacy market has experienced healthy growth. The lockdown limitations and social distancing have functioned as a driving factor for over the counter and prescription drug purchases over the internet. For instance, on 12 July 2021, the leading pharma companies such as Sun Pharma, Lupin, Cadila Healthcare, Torrent Pharma, Dr. Reddy's Labs, and Cipla have come together to invest in a healthcare services firm ABCD Technologies (to be renamed as IndoHealth Services) with an objective of digitalizing healthcare infrastructure in India. Also, according to a report of global professional services firm EY shows that India's potential in the e-pharmacies market will rise to US$18.1 billion by 2023 compared to US$9.3 billion in 2019. And as per Adobe's analysis, there has been a 200% increase in Google Search volumes for COVID-19 related health products. The increasing use of the internet and e-commerce podiums will upsurge the growth of e-pharmacy during the forecast period.
Based on drug type, the market is bifurcated into over the counter (OTC) drugs, prescribed drugs, and others. The over the counter (OTC) drugs segment grabbed the major market in 2020 as OTC refers to a class of medication that can be sold without the need for a prescription and anyone can easily buy medicines with just a click. Moreover, the total sales value of over the counter (OTC) drugs in Great Britain amounted to 3.65 billion USD in 2020.
Based on product type, the market is bifurcated into hair care, skin care, dental, cold and flu, weight management, vitamins & supplements, toiletries, electrical medical devices, pet medicines, and others. The skin care segment ruled the major market and accounted for the maximum share in 2020. The rising awareness about the various benefits of using skin care products has resulted in rising demand over the last few years. This has also boosted the demand for natural and organic skincare products, making it a major segment in this market.
Based on platform, the market is bifurcated into business-to-business (B2B) and business-to-consumer (B2C). The business-to-consumer (B2C) segment grabbed the major market in 2020 and accounted for the maximum revenue during the forecast period. The e-pharmacies works on the collaboration with key companies and provide survives direct to consumers and that is why providing medicines at lesser prices which is the major factor driving the growth of this segment.
For a better understanding of the market adoption of the e-Pharmacy market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), GCC (Saudi Arabia, UAE, Kuwait, Bahrain, Qatar, Oman) and Rest of World. North America constitutes a major market for e-Pharmacy and generated maximum revenue in 2020 owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled workforces.
12 e-PHARMACY MARKET DYNAMICS
16 e-PHARMACY MARKET OPPORTUNITIES
17 e-PHARMACY MARKET TRENDS & INSIGHTS